Oligometastasis and local ablation in the era of systemic targeted and immunotherapy

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy

Abstract Background During these last years, new agents have dramatically improved the survival of the metastatic patients. Oligometastases represent a continuous field of interest in which the integration of metastases-directed therapy and drugs could further improve the oncologic outcomes. Herein...

Full description

Bibliographic Details
Main Authors: Rosario Mazzola, Barbara Alicja Jereczek-Fossa, Davide Franceschini, Slavisa Tubin, Andrea Riccardo Filippi, Maria Tolia, Andrea Lancia, Giuseppe Minniti, Stefanie Corradini, Stefano Arcangeli, Marta Scorsetti, Filippo Alongi
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Radiation Oncology
Subjects:
Oligometastasis
Immunotherapy
Target therapy
Metastases-directed therapy
Online Access:http://link.springer.com/article/10.1186/s13014-020-01544-0

Internet

http://link.springer.com/article/10.1186/s13014-020-01544-0

Similar Items